Overview
Changcun Pan practices in Beijing, China. Pan is rated as a Distinguished expert by MediFind in the treatment of Posterior Fossa Tumor. Their top areas of expertise are Brain Stem Cancer, Posterior Fossa Tumor, Diffuse Midline Glioma H3 K27M-Mutant, and Glioma.
Their clinical research consists of co-authoring 35 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 15 articles in the study of Posterior Fossa Tumor.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Brain Stem CancerPan isDistinguished. Learn about Brain Stem Cancer.
- Diffuse Midline Glioma H3 K27M-Mutant
- Posterior Fossa TumorPan isDistinguished. Learn about Posterior Fossa Tumor.
- Advanced
- Brain TumorPan isAdvanced. Learn about Brain Tumor.
- GliomaPan isAdvanced. Learn about Glioma.
- Gliomatosis CerebriPan isAdvanced. Learn about Gliomatosis Cerebri.
- Experienced
- Aicardi-Goutieres Syndrome
- AstrocytomaPan isExperienced. Learn about Astrocytoma.
- GangliogliomaPan isExperienced. Learn about Ganglioglioma.
- GlioblastomaPan isExperienced. Learn about Glioblastoma.